CellaVision AB (CEVI) – Strategy, SWOT and Corporate Finance Report

CellaVision AB (CEVI) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automated microscopy, and artificial intelligence. The company’s product portfolio includes analyzers for automated medical microscopy analysis, software, and applications for the healthcare and veterinary markets. It has partnerships with major companies that supply cell counters and other hematology equipment. Through its global partners, CellaVision distributes its products in the Americas, Middle East and Africa (EMEA) and Asia–Pacific. CellaVision is headquartered in Lund, Scania, Sweden.

Scope

• Detailed information on CellaVision AB required for business and competitor intelligence needs

• A study of the major internal and external factors affecting CellaVision AB in the form of a SWOT analysis

• An in-depth view of the business model of CellaVision AB including a breakdown and examination of key business segments

• News about CellaVision AB, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of CellaVision AB and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess CellaVision AB as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on CellaVision ABs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Constitution Medical, Inc.

Circassia AB

ContextVision AB

Senzime AB

Cellix Ltd

Biotage AB

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

CellaVision AB - Key Facts

CellaVision AB - Key Employees

CellaVision AB - Key Employee Biographies

CellaVision AB - Major Products and Services

CellaVision AB - History

CellaVision AB - Company Statement

CellaVision AB - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

CellaVision AB - Business Description

Product Category: Instruments

Performance

Product Category: Other

Performance

Product Category: Reagents

Performance

Geographical Segment: APAC

Performance

Geographical Segment: EMEA

Performance

Geographical Segment: The Americas

Performance

R&D Overview

CellaVision AB - Corporate Strategy

CellaVision AB - SWOT Analysis

SWOT Analysis - Overview

CellaVision AB - Strengths

CellaVision AB - Weaknesses

CellaVision AB - Opportunities

CellaVision AB - Threats

CellaVision AB - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

CellaVision AB, Medical Equipment, Deals By Year, 2017 to YTD 2023

CellaVision AB, Medical Equipment, Deals By Type, 2017 to YTD 2023

CellaVision AB, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 05, 2023: CellaVision: Bulletin from annual general meeting 2023

May 05, 2023: Bulletin from the Annual General Meeting of CellaVision AB (publ

Apr 21, 2023: Invitation to presentation of the CellaVision report for the first quarter 2023 on May 4, at 11:00 CEST

Apr 17, 2023: CellaVision announces preliminary first quarter results 2023

Apr 03, 2023: Cellavision Notice Of Annual General Meeting

Jan 24, 2023: CellaVision's Invitation for presentation of the report for the fourth quarter 2022 on February 7, at 11:00 CET

Oct 26, 2022: CellaVision announces Nomination Committee for the Annual General Meeting 2023

Oct 12, 2022: Invitation to presentation of the CellaVision report for the third quarter 2022

Jan 13, 2022: Magnus Blixt leaves his position as CFO of CellaVision

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

CellaVision AB, Key Facts

CellaVision AB, Key Employees

CellaVision AB, Key Employee Biographies

CellaVision AB, Major Products and Services

CellaVision AB, History

CellaVision AB, Other Locations

CellaVision AB, Subsidiaries

CellaVision AB, Key Competitors

CellaVision AB, Ratios based on current share price

CellaVision AB, Annual Ratios

CellaVision AB, Annual Ratios (Cont…1)

CellaVision AB, Annual Ratios (Cont…2)

CellaVision AB, Interim Ratios

CellaVision AB, Medical Equipment, Deals By Year, 2017 to YTD 2023

CellaVision AB, Medical Equipment, Deals By Type, 2017 to YTD 2023

CellaVision AB, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

CellaVision AB, Performance Chart (2018 – 2022)

CellaVision AB, Ratio Charts

CellaVision AB, Medical Equipment, Deals By Year, 2017 to YTD 2023

CellaVision AB, Medical Equipment, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports